EU Project Empowers Elderly to Live Independently

Researchers in the EU-funded PERSONA (Perceptive spaces promoting independent aging) project are drawing on a range of advanced technologies to empower the elderly and support them in their efforts to maintain both their independence and a good quality of life.

Over EUR 6 million of the project's EUR 11.6 million budget comes from the 'Information Society Technologies' Thematic area of the Sixth Framework Programme (FP6). PERSONA began in 2007 and is scheduled to run until 2010.

The proportion of senior citizens in Europe's population is rising steadily, and by 2020 a quarter of this population will be over 65 years of age. Many of these people will suffer from health conditions and memory problems that could reduce their quality of life and make it harder for them to live independently.

The concept of Ambient Assisted Living (AAL) refers to the range of technologies and services, particularly those based on Information and Communication Technologies (ICTs), that can be used to help the elderly remain independent and maintain a good quality of life.

The aim of the PERSONA project is to further the development of AAL products and services that are affordable, easy to use and commercially viable. Crucially, the project partners are developing an integrated technological platform that seamlessly links up the different products and services. Furthermore, the team is working on certain hardware developments, such as intelligent textiles for use in devices that interact with the users, short-range communication networks to link up sensors and systems, and an indoor localisation system.

"Our aim is to help the user[s] to be autonomous, to increase their self confidence and [to] increase their participation in society," explained Siri Bjørvig of the Norwegian Centre for Telemedicine, one of the project partners.

With this in mind, the partners are focusing their efforts on four scenarios, which involve safety, mobility, communication and autonomy. As its name suggests, the 'feel safe' scenario looks at AAL services designed to prevent injuries in the home environment; this gives users the confidence to live without the constant presence of a carer. If someone living alone has an accident or collapses, there are AAL solutions that can detect the problem and alert a neighbour or the health services, for example. Similarly, the system could alert the users if they forget to switch the oven off.

The mobility scenario investigates how senior citizens can be supported when they leave their homes, with the help of a mobile device that reminds them of errands they have to run, for example.

The 'keep in touch' scenario places emphasis on preventing isolation and loneliness, by providing users with ICT tools to help them create and maintain social contacts and participate in community life.

Finally, the 'be autonomous' package is designed to assist the users throughout the day, providing guidance on daily activities to boost independence and autonomy while minimising risks. For instance, the system could remind users to take medication at a certain time.

The technologies developed by PERSONA are set to undergo tests at three sites in Denmark, Spain and Italy.

For further information, please visit:
http://www.aal-persona.org

Copyright ©European Communities, 2009
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Open Call HORIZON-MISS-2022-CANCER-01-04…

The overall goal of the Mission on Cancer[1] and the Europe's Beating Cancer Plan[2] includes a better quality of life for patients and their families living with, and after, cancer. Project...

Insilico Medicine Raises $60 Million in …

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with...

Philips' Future Health Index 2022 Report…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as...

KTU Researchers Investigate the Links Be…

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled. Using artificial...

Speech Analysis App Predicts Worsening H…

A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late...

Screening for Diabetic Retinopathy Prove…

Both telemedicine and community screening for diabetic retinopathy (DR) in rural and urban settings are cost-effective in China, and telemedicine screening programs are more cost-effective, according to a study led...

App Detecting Jaundice in Babies a Succe…

A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study...

Researchers Develop Smartphone-Powered M…

A University of Minnesota Twin Cities research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by...

InterSystems Wins Data Driven Product of…

InterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced it received the prestigious Data Driven Product of the...

Siemens Healthineers Introduces Symbia P…

Siemens Healthineers introduces Symbia Pro.specta™, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with CE Mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging...

Oracle Purchase of Cerner Approved

Oracle Corporation (NYSE: ORCL) announced that all required antitrust approvals have been obtained for its proposed acquisition of Cerner, including European Commission clearance. Cerner is a leading provider of digital...